期刊文献+

新基因Nischarin生物信息学分析及初步验证 被引量:1

Initial Bioinformatics Analysis and Verification of a Novel Gene Named Nischarin
原文传递
导出
摘要 目的:对新基因Nischarin进行生物信息学分析,探索其新功能特征,并通过实验进行初步验证。方法:用生物信息学方法对Nischarin进行初步分析,阐明了它的基因结构、染色体定位、编码蛋白质的理化性质、相互作用基因、相互作用蛋白、亚细胞定位、蛋白质功能域等信息。最后采用细胞免疫荧光对其DNA结合位点进行初步验证。结果:对新基因Nischarin的上述性质进行了有效的预测,分析表明该基因结构复杂,相互作用基因或蛋白多,亚细胞分布预测复杂。验证了Nishcarin存在的DNA结合位点。结论:通过生物信息学分析,表明新基因Nischarin是一个复杂的基因,可能存在的多种蛋白表达形式、这些不同的蛋白可能存在不同的亚细胞分布,且该蛋白可能与多种蛋白存在相互作用,上述基因和蛋白特性可能是Ⅰ型咪唑啉受体(Imidazoline-1 receptor,I1R)复杂药理学作用的分子基础。 Objective: To explore the new function of the novel gene named Nischarin and verify the real nature, the gene was an-alyzed by the bioinformatics analysis. Methods: Initial bioinformatics analysis was performed on the novel gene named Nischarin. Its gene structure, genome localization, the physical and chemical characteristics of the protein, subcellular localization of the protein, func- tional domain and so on was predicted. On the basis of the predicted result, the DNA binding motifs (Leucine zipper pattern) was verified by cell immunofluorescence. Results: Through efficient bioinformatics analysis, Nischafin gene's structure is very complex. It may be ex- pressed by many kinds of proteins. The proteins have no signal peptide and it's subcellular localization is complex. There may be a DNA binding motifs in the Nischarin protein. Conclusion: Nischarin is a very complex gene, it may be expressed many kinds of proteins which maybe have different subcellular localization. Nischarin protein has interaction with many proteins. This may be the molecular basis for I1R complex pharmacology.
出处 《现代生物医学进展》 CAS 2012年第32期6201-6206,共6页 Progress in Modern Biomedicine
基金 国家自然基金重点项目(30930040) 国家自然基金青年项目(30701016 81102426) 北京市自然基金面上项目(7082073)
关键词 NISCHARIN 生物信息学 Ⅰ型咪唑啉受体 可变剪接异构体 Nischarin Bioinformatics analysis I1R Isoforms
  • 相关文献

参考文献2

二级参考文献22

  • 1Piletz JE,Ivanov TR,Sharp JD,et al.Imidazoline receptor antisera-selected (IRAS) cDNA:cloning and characterization[J].DNA Cell Biol,2000,19(6):319-329.
  • 2Sun Z,Change CH,Ernsberger P.Identification of IRAS/nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells[J].J Neurochem,2007,101(1):99-108.
  • 3Wang B,Liu Y,Li J,et al.Generation and characterization of novel human IRAS monoclonal antibodies[J].J Biomed Biotechnol,2009,2009:973754-973762.
  • 4Gmveley BR.Alternative splicing:increasing diversity in the proteomic world[J].Trends Genet,2001,17(2):100.
  • 5Modrek B,Lee C.A genomic view of alternative splicing[J].Nat Genet,2002,30(1):13.
  • 6Caceres JF,Komblihtt AR.Alternative splicing:multiple control mechanisms and involvement in human disease[J].Trends Genet,2002,18(4):186.
  • 7Mironov AA,Kichett JW,Gelfand MS.Frequent alternative splicing of human genes[J].Genome Res,1999,9(12):1288.
  • 8Dehay C,Kennedy H.Transcriptional regulation and alternative splicing make for better brains[J].Neuron,2009,62(4):455-457.
  • 9Pio R,Montuenga LM.Alternative splicing in lung cancer[J].Thorac Oncol,2009,4(6):674-678.
  • 10Lim KP,Hong WJ.Human nischarin/imidazoline receptor antisera-selected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region[J].J Biol Chem,2004,279(24):54770-54782.

共引文献5

同被引文献16

  • 1Wei XL, Su RB, Wu N, et al. Agmatine inhibits morphine- induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats [J]. Eur Neuropsychopharmacol, 2007, 17(12) : 790-799.
  • 2Hong S, Kim CY, Lee WS, et al. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model[J]. Exp Eye Res, 2010, 90(1): 97-103.
  • 3Gibson DA, Harris BR, Rogers DT, et al. Radioligand binding studies reveal agrnatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil [J]. Brain Res, 2002, 952(1): 71-77.
  • 4Weng XC, Gai XD, Zheng JQ, et al. Agmatine blocked voltage- gated calcium channel in cultured rat hippocampal neurons[J]. Acta Pharmocol Sin, 2003, 24(8): 746-750.
  • 5Li J, Li X, Pei G, et ol. Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine [ J]. A cta Phantuol Sin, 1999, 20(4): 375-380.
  • 6Schafer U, Burgdorf C, Engelhardt A, et al. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors [J]. J Pharmacol Exp Ther, 2002, 303(3): 1163-1170.
  • 7Head GA, Burke SL. I1 imidazolinc receptors in cardiovascular regulation: the place of rilmenidine[J]. Am J Hypertens ,2000, 13(6 Pt 2): 89S-98S.
  • 8Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view [ J] . Addiction, 2000, 95(Suppl 2): $91-Sl17.
  • 9Robinson TE, Bcrridge KC. Incentive-sensitization and addiction [J].Addiction, 2001, 96(1): 103-114.
  • 10Nestler EJ, Berhow MT, Brodkin ES. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways[J]. MolPsychiatry, 1996, 1(3): 190-199.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部